Daniëlle C.H. Jacobs

1.5k total citations · 1 hit paper
9 papers, 951 citations indexed

About

Daniëlle C.H. Jacobs is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Daniëlle C.H. Jacobs has authored 9 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Genetics. Recurrent topics in Daniëlle C.H. Jacobs's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Daniëlle C.H. Jacobs is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Daniëlle C.H. Jacobs collaborates with scholars based in Netherlands, United States and Poland. Daniëlle C.H. Jacobs's co-authors include Lukas A. Oomen, Michel de Weers, Tom Vink, Joost M. Bakker, Jan G. J. van de Winkel, Jerry W. Slootstra, Kenneth C. Anderson, Paul W.H.I. Parren, Matthias Peipp and Yu‐Tzu Tai and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Daniëlle C.H. Jacobs

9 papers receiving 934 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors

2010 746 citations Michel de Weers, Yu‐Tzu Tai et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniëlle C.H. Jacobs Netherlands	4	562	514	366	298	206	9	951
Pamela L. Clemens United States	15	557 1.0×	468 0.9×	329 0.9×	191 0.6×	164 0.8×	33	803
Thomas G. Martin United States	15	593 1.1×	534 1.0×	446 1.2×	150 0.5×	138 0.7×	79	946
Michael S. van der Veer Netherlands	4	731 1.3×	528 1.0×	429 1.2×	246 0.8×	268 1.3×	7	1.0k
Jakub Krejcik Denmark	10	795 1.4×	593 1.2×	449 1.2×	183 0.6×	322 1.6×	13	1.1k
Jaime Bald United States	8	639 1.1×	499 1.0×	339 0.9×	172 0.6×	258 1.3×	10	903
Marielle Chiron France	12	321 0.6×	440 0.9×	299 0.8×	109 0.4×	125 0.6×	44	745
Mike Zhong China	6	516 0.9×	566 1.1×	357 1.0×	233 0.8×	206 1.0×	21	881
Bryan Ciccarelli United States	13	316 0.6×	264 0.5×	530 1.4×	119 0.4×	302 1.5×	34	1.1k
Nisha S. Joseph United States	13	645 1.1×	389 0.8×	498 1.4×	63 0.2×	68 0.3×	69	783

Countries citing papers authored by Daniëlle C.H. Jacobs

Since Specialization

Citations

This map shows the geographic impact of Daniëlle C.H. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniëlle C.H. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniëlle C.H. Jacobs more than expected).

Fields of papers citing papers by Daniëlle C.H. Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniëlle C.H. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniëlle C.H. Jacobs. The network helps show where Daniëlle C.H. Jacobs may publish in the future.

Co-authorship network of co-authors of Daniëlle C.H. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Daniëlle C.H. Jacobs. A scholar is included among the top collaborators of Daniëlle C.H. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniëlle C.H. Jacobs. Daniëlle C.H. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Groothuis, Patrick G., Daniëlle C.H. Jacobs, Aloys L.A. Sesink, et al.. (2021). Abstract 926: BYON3521, a novel effective and safe c-Met targeting antibody-drug conjugate. Cancer Research. 81(13_Supplement). 926–926. 2 indexed citations

Groothuis, Patrick G., Daniëlle C.H. Jacobs, Kim Berentsen, et al.. (2021). Abstract 925: Introduction to the preclinical profile of SYD1875, a novel site-specifically conjugated duocarmycin-based 5T4-targeting antibody-drug conjugate. Cancer Research. 81(13_Supplement). 925–925. 3 indexed citations

Dokter, Wim H.A., Fred A. Dijcks, Patrick G. Groothuis, et al.. (2020). Abstract 4043: SYD985 synergy with PARP inhibitors (PARPi) in human tumor cell lines and patient-derived xenografts (PDXs). Cancer Research. 80(16_Supplement). 4043–4043. 1 indexed citations

Lee, Miranda M.C. van der, Patrick G. Groothuis, Ruud Ubink, et al.. (2015). The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers. Molecular Cancer Therapeutics. 14(3). 692–703. 141 indexed citations

Ubink, Ruud, Daniëlle C.H. Jacobs, Diels van den Dobbelsteen, et al.. (2014). Abstract 2651: Impressive efficacy and safety profile of a novel generation duocarmycin-based HER2-targeting ADC. Cancer Research. 74(19_Supplement). 2651–2651. 1 indexed citations

Groothuis, Patrick G., Eline M. Loosveld, Daniëlle C.H. Jacobs, et al.. (2014). Abstract 2652: In vitro and in vivo antitumor activity of SYD985, a novel HER2-targeting ADC: a comparison with T-DM1. Cancer Research. 74(19_Supplement). 2652–2652. 2 indexed citations

Weers, Michel de, Yu‐Tzu Tai, Michael S. van der Veer, et al.. (2010). Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors. The Journal of Immunology. 186(3). 1840–1848. 746 indexed citations breakdown →

Tai, Yu‐Tzu, Michel de Weers, Xianfeng Li, et al.. (2009). Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication.. Blood. 114(22). 608–608. 9 indexed citations

Szczepański, Tomasz, Vincent H. J. van der Velden, Patricia G. Hoogeveen, et al.. (2003). Vδ2-Jα rearrangements are frequent in precursor-B–acute lymphoblastic leukemia but rare in normal lymphoid cells. Blood. 103(10). 3798–3804. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact